SS INNOVATIONS INTERNATIONAL, INC. Increase (Decrease) in Accounts Receivable
SS INNOVATIONS INTERNATIONAL, INC. (SSII) reported Increase (Decrease) in Accounts Receivable of $4.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $4.04M, a 11.84% increase year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $245.11K.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $6.95M, a 504.99% increase year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $3.75M, a 1313.12% increase year-over-year.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accounts receivable for fiscal 2025 was $13.04M, a 166.61% increase from fiscal 2024.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accounts receivable for fiscal 2024 was $4.89M, a 59.20% increase from fiscal 2023.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accounts receivable for fiscal 2023 was $3.07M, a 193.96% increase from fiscal 2022.
- SS INNOVATIONS INTERNATIONAL, INC. increase (decrease) in accounts receivable for fiscal 2022 was $1.04M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.29M 10-Q · filed 2026-08-13 | $11.24M derived: sum of 3 quarters · filed 2026-08-13 | $14.99M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $245.11K 10-Q · filed 2026-05-13 | $7.20M derived: sum of 2 quarters · filed 2026-05-13 | $10.94M derived: sum of 3 quarters · filed 2026-05-13 | $14.56M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $10.70M derived: sum of 2 quarters · filed 2026-03-10 | $14.31M derived: sum of 3 quarters · filed 2026-08-13 | $13.04M 10-K · filed 2026-03-10 | ||
| 2025-09-30 | $3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $7.36M derived: sum of 2 quarters · filed 2026-08-13 | $6.09M 10-Q · filed 2025-10-28 | $7.24M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.34M 10-Q · filed 2026-08-13 | $3.49M derived: sum of 3 quarters · filed 2026-08-13 | $3.75M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$1.28M 10-Q · filed 2026-05-13 | -$126.91K derived: sum of 2 quarters · filed 2026-05-13 | $138.40K derived: sum of 3 quarters · filed 2026-05-13 | $428.17K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.41M derived: sum of 2 quarters · filed 2026-03-10 | $1.70M derived: sum of 3 quarters · filed 2026-03-10 | $4.89M 10-K · filed 2026-03-10 | ||
| 2024-09-30 | $265.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $555.08K derived: sum of 2 quarters · filed 2025-10-28 | $3.74M 10-Q · filed 2025-10-28 | $3.20M 10-Q · filed 2024-11-14 | $4.19M derived: sum of 4 quarters · filed 2025-10-28 | |
| 2024-06-30 | $289.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $3.48M 10-Q · filed 2025-08-06 | $2.70M 10-Q · filed 2024-09-06 | $3.92M derived: sum of 3 quarters · filed 2025-08-06 | $5.51M derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | $3.19M 10-Q · filed 2025-05-14 | $3.63M derived: sum of 2 quarters · filed 2025-05-14 | $5.22M derived: sum of 3 quarters · filed 2025-05-14 | $6.07M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $444.18K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | $2.03M derived: sum of 2 quarters · filed 2025-04-15 | $2.88M derived: sum of 3 quarters · filed 2025-04-15 | $3.07M 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $1.59M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-04-01 | $2.44M derived: sum of 2 quarters · filed 2025-04-01 | $2.63M 10-Q/A · filed 2025-04-01 | $3.82M 10-Q · filed 2024-11-14 | $3.03M derived: sum of 4 quarters · filed 2025-04-01 | |
| 2023-06-30 | $849.71K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-03-10 | $1.04M 10-Q/A · filed 2025-03-10 | $1.44M derived: sum of 3 quarters · filed 2025-03-10 | $1.99M derived: sum of 4 quarters · filed 2025-03-10 | ||
| 2023-03-31 | $190.48K 10-Q/A · filed 2025-02-19 | $590.11K derived: sum of 2 quarters · filed 2025-02-19 | $1.14M derived: sum of 3 quarters · filed 2025-02-19 | |||
| 2022-12-31 | $399.63K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-12-20 | $944.91K derived: sum of 2 quarters · filed 2025-01-14 | $1.04M 10-K/A · filed 2024-12-20 | |||
| 2022-09-30 | $545.28K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-01-14 | $645.28K 10-Q/A · filed 2025-01-14 | ||||
| 2022-06-30 | $100.00K 10-Q/A · filed 2025-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |